December 2021 | Page 3 of 12 | Institute for Translational Medicine and Science

New Jersey bucked U.S. trend in drug overdoses last year, but 2021 could be the deadliest.

by | Dec 23, 2021 | News

New Jersey may have been an outlier when the United States surpassed 100,000 drug overdose deaths last year, but the Garden State is now on a path toward its own somber milestone in a decade-long epidemic. Preliminary data shows New Jersey is on pace to end 2021 with...

Apply for a 2022 Global Health Institute Seed Grant

by | Dec 22, 2021 | News

Rutgers Global Health Institute awards Global Health Seed Grants to faculty conducting collaborative, interdisciplinary activities that address health inequities in New Jersey and around the world. With these grants, we aim to help faculty pursue new ideas and seed...

Merck’s Covid-19 Pill Backed by FDA Advisers

by | Dec 22, 2021 | News

An outside panel of scientific advisers to the Food and Drug Administration narrowly recommended the agency authorize the experimental Covid-19 oral antiviral from Merck MRK -0.74% & Co. and partner Ridgeback Biotherapeutics LP. The panel, known as the...

Power and Participation: How Community Health Centers Address the Determinants of the Social Determinants of Health

by Aaron Bender | Dec 21, 2021 | News

NEJM Catalyst Innovations in Care Delivery The health inequities revealed by the Covid-19 pandemic, along with heightened awareness of racial justice issues, present opportunities for leaders, especially at community-based health centers, to engage with, listen to,...

Rutgers–Camden Researcher Explains Omicron Variant’s Impact on the Stock Market.

by | Dec 21, 2021 | News

With the spread of the COVID-19 Omicron variant, investors across the country have seen substantial hits to their portfolios. Richard Michelfelder, a clinical associate professor in the Rutgers–Camden School of Business whose research focuses on regulation, utility...

« Older Entries

Next Entries »

New Jersey bucked U.S. trend in drug overdoses last year, but 2021 could be the deadliest.

Apply for a 2022 Global Health Institute Seed Grant

Merck’s Covid-19 Pill Backed by FDA Advisers

Power and Participation: How Community Health Centers Address the Determinants of the Social Determinants of Health

Rutgers–Camden Researcher Explains Omicron Variant’s Impact on the Stock Market.

Recent Posts

Archives

Categories